Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019)

医学 重症监护室 倾向得分匹配 蛛网膜下腔出血 比例危险模型 内科学 回顾性队列研究 人口 危险系数 混淆 创伤性脑损伤 冲程(发动机) 生存分析 机械工程 置信区间 环境卫生 精神科 工程类
作者
Yongwei Huang,Ye Zhang,Zongping Li,Xiao-Shuang Yin
出处
期刊:Frontiers in Immunology [Frontiers Media]
卷期号:14 被引量:5
标识
DOI:10.3389/fimmu.2023.1235266
摘要

Non-traumatic subarachnoid hemorrhage (SAH), primarily due to the rupture of intracranial aneurysms, contributes significantly to the global stroke population. A novel biomarker, pan-immune-inflammation value (PIV) or called the aggregate index of systemic inflammation (AISI), linked to progression-free survival and overall survival in non-small-cell lung cancer and mortality in Coronavirus Disease 2019 (COVID-19) patients, has surfaced recently. Its role in non-traumatic SAH patients, however, remains under-researched. This study aims to determine the relationship between PIV and all-cause mortality in non-traumatic SAH patients.A retrospective analysis was conducted using data from the Medical Information Mart for Intensive Care (MIMIC-IV) database to examine the association between PIV and all-cause mortality in critically ill patients with non-traumatic SAH. PIV measurements were collected at Intensive Care Unit (ICU) admission, and several mortality measures were examined. To control for potential confounding effects, a 1:1 propensity score matching (PSM) method was applied. The optimal PIV cutoff value was identified as 1362.45 using X-tile software that is often used to calculate the optimal cut-off values in survival analysis and continuous data of medical or epidemiological research. The relationship between PIV and short- and long-term all-cause mortality was analyzed using a multivariate Cox proportional hazard regression model and Kaplan-Meier (K-M) survival curve analysis. Interaction and subgroup analyses were also carried out.The study included 774 non-traumatic SAH patients. After PSM, 241 pairs of score-matched patients were generated. The Cox proportional hazard model, adjusted for potential confounders, found a high PIV (≥ 1362.45) independently associated with 90-day all-cause mortality both pre- (hazard ratio [HR]: 1.67; 95% confidence intervals (CI): 1.05-2.65; P = 0.030) and post-PSM (HR: 1.58; 95% CI: 1.14-2.67; P = 0.042). K-M survival curves revealed lower 90-day survival rates in patients with PIV ≥ 1362.45 before (31.1% vs. 16.1%%, P < 0.001) and after PSM (68.9% vs. 80.9%, P < 0.001). Similarly, elevated PIV were associated with increased risk of ICU (pre-PSM: HR: 2.10; 95% CI: 1.12-3.95; P = 0.02; post-PSM: HR: 2.33; 95% CI: 1.11-4.91; P = 0.016), in-hospital (pre-PSM: HR: 1.91; 95% CI: 1.12-3.26; P = 0.018; post-PSM: 2.06; 95% CI: 1.10-3.84; P = 0.034), 30-day (pre-PSM: HR: 1.69; 95% CI: 1.01-2.82; P = 0.045; post-PSM: 1.66; 95% CI: 1.11-2.97; P = 0.047), and 1-year (pre-PSM: HR: 1.58; 95% CI: 1.04-2.40; P = 0.032; post-PSM: 1.56; 95% CI: 1.10-2.53; P = 0.044) all-cause mortality. The K-M survival curves confirmed lower survival rates in patients with higher PIV both pre- and post PSM for ICU (pre-PSM: 18.3% vs. 8.4%, P < 0.001; post-PSM:81.7 vs. 91.3%, P < 0.001), in-hospital (pre-PSM: 25.3% vs. 12.8%, P < 0.001; post-PSM: 75.1 vs. 88.0%, P < 0.001), 30-day (pre-PSM: 24.9% vs. 11.4%, P < 0.001; post-PSM:74.7 vs. 86.3%, P < 0.001), and 1-year (pre-PSM: 36.9% vs. 20.8%, P < 0.001; P = 0.02; post-PSM: 63.1 vs. 75.1%, P < 0.001) all-cause mortality. Stratified analyses indicated that the relationship between PIV and all-cause mortality varied across different subgroups.In critically ill patients suffering from non-traumatic SAH, an elevated PIV upon admission correlated with a rise in all-cause mortality at various stages, including ICU, in-hospital, the 30-day, 90-day, and 1-year mortality, solidifying its position as an independent mortality risk determinant. This study represents an attempt to bridge the current knowledge gap and to provide a more nuanced understanding of the role of inflammation-based biomarkers in non-traumatic SAH. Nevertheless, to endorse the predictive value of PIV for prognosticating outcomes in non-traumatic SAH patients, additional prospective case-control studies are deemed necessary.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
某不科学的萌萌完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
1秒前
2秒前
cedricleonard完成签到,获得积分10
2秒前
弦越应助yy采纳,获得10
3秒前
3秒前
4秒前
排除法发布了新的文献求助10
5秒前
bkagyin应助卡卡西采纳,获得10
5秒前
wangxw完成签到,获得积分10
6秒前
6秒前
ShiBoSong发布了新的文献求助10
6秒前
崔梦楠发布了新的文献求助20
7秒前
打打应助StrawCc采纳,获得10
7秒前
lkxpsy发布了新的文献求助30
7秒前
8秒前
热情奇异果完成签到,获得积分10
8秒前
lingkai发布了新的文献求助10
9秒前
人机分离10米一键荡平万邦完成签到,获得积分10
9秒前
xvping完成签到,获得积分10
9秒前
芙蓉影破应助jja881采纳,获得20
10秒前
CipherSage应助郭素玲采纳,获得10
10秒前
黄鹤楼发布了新的文献求助10
10秒前
852应助黑天的宇宙采纳,获得10
10秒前
10秒前
Gin发布了新的文献求助10
10秒前
11秒前
胡图图发布了新的文献求助10
12秒前
1410完成签到,获得积分10
12秒前
12秒前
黑面包的坑完成签到,获得积分10
12秒前
13秒前
13秒前
13秒前
14秒前
任性子骞完成签到,获得积分10
14秒前
tgd发布了新的文献求助10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
Pulse width control of a 3-phase inverter with non sinusoidal phase voltages 777
Signals, Systems, and Signal Processing 610
Research Methods for Applied Linguistics: A Practical Guide 600
Research Methods for Applied Linguistics 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6406289
求助须知:如何正确求助?哪些是违规求助? 8225572
关于积分的说明 17441853
捐赠科研通 5458961
什么是DOI,文献DOI怎么找? 2884512
邀请新用户注册赠送积分活动 1860862
关于科研通互助平台的介绍 1701701